Proteomic-Based Discovery of Predictive Biomarkers for Drug Therapy Response and Personalized Medicine in Chronic Immune Thrombocytopenia.

Gilanchi S, Faranoush M, Daskareh M, Sadjjadi FS, Zali H, Ghassempour A, Rezaei Tavirani M

Open source

DOI
10.1155/2023/9573863
Published
2023
Container
BioMed research international
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2023/9573863,
  title = {Proteomic-Based Discovery of Predictive Biomarkers for Drug Therapy Response and Personalized Medicine in Chronic Immune Thrombocytopenia.},
  author = {Gilanchi S and Faranoush M and Daskareh M and Sadjjadi FS and Zali H and Ghassempour A and Rezaei Tavirani M},
  year = {2023},
  journal = {BioMed research international},
  doi = {10.1155/2023/9573863},
  url = {https://doi.org/10.1155/2023/9573863}
}

RIS

TY  - JOUR
TI  - Proteomic-Based Discovery of Predictive Biomarkers for Drug Therapy Response and Personalized Medicine in Chronic Immune Thrombocytopenia.
AU  - Gilanchi S
AU  - Faranoush M
AU  - Daskareh M
AU  - Sadjjadi FS
AU  - Zali H
AU  - Ghassempour A
AU  - Rezaei Tavirani M
PY  - 2023
JO  - BioMed research international
DO  - 10.1155/2023/9573863
UR  - https://doi.org/10.1155/2023/9573863
ER  - 

APA

S, G., M, F., M, D., FS, S., H, Z., A, G., & M, R. T. (2023). Proteomic-Based Discovery of Predictive Biomarkers for Drug Therapy Response and Personalized Medicine in Chronic Immune Thrombocytopenia.. BioMed research international. https://doi.org/10.1155/2023/9573863

Source records